HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £6.78m
- £7.88m
REG - Hemogenyx Pharma Plc - Second Patient Treated with HG-CT-1 CAR-T Therapy
AnnouncementREG - Hemogenyx Pharma Plc - Final Results
AnnouncementRCS - Hemogenyx Pharma Plc - FDA Annual Report
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Hemogenyx Pharma Plc - First Patient Safety
AnnouncementREG - Stock Exch Notice - Admission to Trading - 18/03/2025
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Hemogenyx Pharma Plc - Recruitment of Second Patient for Clinical Trials
AnnouncementREG - Stock Exch Notice - Admission to Trading - 14/03/2025
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Hemogenyx Pharma Plc - Conversion of convertible loan notes
AnnouncementREG - Hemogenyx Pharma Plc - Institutional investment
AnnouncementREG - Hemogenyx Pharma Plc - First-in-Human Treatment with HG-CT-1
AnnouncementREG - Hemogenyx Pharma Plc - Issue of convertible loan notes
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 15/01/2025
AnnouncementREG - Hemogenyx Pharma Plc - Placing to raise £340,000
AnnouncementREG - Hemogenyx Pharma Plc - Change of Company Secretary and Registered Office
Announcement